THE NEXT BIG THING IN INFECTIOUS DISEASE TESTING

Now Available! Talis One™ delivers rapid, accurate point-of-care diagnostic testing into a variety of healthcare settings.

Watch Video

CLINICAL VALUE
OPERATIONAL EXCELLENCE

Transforming diagnostics to provide highly accurate, affordable molecular testing that enables rapid triage and treatment in a variety of CLIA-waived settings.

Learn More

TEST TO STAY
MINIMIZE DISRUPTIONS

The Talis One COVID-19 Test System expands access to lab-quality molecular testing to a variety of healthcare settings.

Learn More

EXCELLENCE
AT THE POINT OF CARE

With access to lab-quality molecular diagnostics at the point of need, clinicians get timely results for actionable decision making. In the future, our portfolio of point-of-care diagnostic tests will include:

Respiratory Health
  • COVID-19
  • COVID-19/ Influenza A/B
Sexual Health
  • CT/NG
  • CT/NG/Mgen/Trich
  • HSV
Women’s Health
  • UTI
  • Vaginitis
  • GBS

In development and not available for sale.

MEET THE
LOCALIZED SOLUTION

Talis strives to deliver excellence in diagnostics to help combat the spread of infectious disease. We deploy to various healthcare settings and offer lab-quality testing which is:

Accurate
Rapid
Easy-to-Use

See how you can drive better patient care with the Talis One™ test system.

Built Compact
For More Impact

The Talis One COVID-19 Test System is built with compact performance in mind. It offers a sample-to-answer molecular workflow which integrates sample preparation, nucleic acid extraction, purification, amplification, and detection of the viral genomic target sequence. 

Each Talis One test (shown here) employs a single-use, self-contained, room temperature stable test cartridge that includes the necessary reagents to perform the NAAT (Nucleic Acid Amplification Test.) 

Latest News

3 Lessons from the emergence of the SARS-CoV-2 Delta variant

| Article | No Comments
The emergence of the SARS-CoV-2 Delta variant highlights the importance of widespread vaccination and the ongoing need for accurate testing. New variants can quickly change the public health situation Positive…

Addressing Healthcare disparities in the US with Point-of-Care Testing

| Article | No Comments
Healthcare disparities in the US have become strikingly apparent throughout the COVID-19 pandemic, affecting historically underserved populations (e.g., lower-income households, Black and Minority Americans, immigrants, people with disabilities, rural populations,…

Get in touch

Put the Talis One solution to work for you. Connect with us for information about our products and company updates.

Contact us